Showing results (431-440 of 453) with videos related to

Sort By:
Pageof 46
Molecular Cancer Therapeutics|May 11, 2019
Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical ModelsMehran Makvandi, Hwan Lee, Laura N Puentes, et al.
The Journal of Clinical Investigation|March 7, 2018
A PET imaging agent for evaluating PARP-1 expression in ovarian cancerMehran Makvandi, Austin Pantel, Lauren Schwartz, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Genetic Code Expansion and Enzymatic Modifications as Accessible Methods for Studying Site-Specific Post-Translational Modifications of Alpha-Synuclein and TauIbrahim G Saleh, Marie Shimogawa, Jennifer Ramirez, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
In vivo imaging of reactive oxygen species after myocardial ischemia-reperfusion injury: a large animal multimodal imaging and transcriptomic studySophia Swago, Chiara Camillo, Marina Awad, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 15, 2019
Breast Cancer 18F-ISO-1 Uptake as a Marker of Proliferation StatusElizabeth S McDonald, Robert K Doot, Anthony J Young, et al.
Protein Science : a Publication of the Protein Society|September 13, 2025
Genetic code expansion and enzymatic modifications as accessible methods for studying site-specific post-translational modifications of alpha-synuclein and tauIbrahim G Saleh, Marie Shimogawa, Jennifer Ramirez, et al.
Plos One|November 13, 2014
Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicityNicholas J Izzo, Jinbin Xu, Chenbo Zeng, et al.
Molecular Imaging and Biology|March 29, 2023
Identification of a Putative α-synuclein Radioligand Using an in silico Similarity SearchBieneke Janssen, Guilong Tian, Zsofia Lengyel-Zhand, et al.
EJNMMI Radiopharmacy and Chemistry|October 27, 2023
Highlight selection of radiochemistry and radiopharmacy developments by editorial boardJean DaSilva, Clemens Decristoforo, Robert H Mach, et al.
JCI Insight|January 19, 2017
A patient-derived-xenograft platform to study BRCA-deficient ovarian cancersErin George, Hyoung Kim, Clemens Krepler, et al.
Pageof 46